The Latest
-
How Much Will The Tesla Stock Bubble Inflate?
-
Mesoblast expands compassionate use COVID-19 program
-
Oppenheimer: 3 “Strong Buy” Stocks With Over 30% Upside Ahead
-
Biogen: Approval Prospects for Aducanumab Amount to a Flip of a Coin, Says J.P. Morgan